1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
"Dementia Care and Caregiver Support Intervention Research - Stage I Only" is currently closed and not accepting applications.
Dementia Care and Caregiver Support Intervention Research - Stage I Only is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH).
This Notice of Funding Opportunity (NOFO) invites NIH Stage Model Stage I research applications focused on developing behavioral interventions for individuals living with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) and/or their care partners or caregivers.
The awards support mechanism-focused Stage I research to develop, modify, adapt, or refine principle-based behavioral interventions, establish acceptability and feasibility, and develop intervention fidelity procedures for later-stage clinical trials.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Eligible applicants include non-profits (with 501(c)(3) status or other Native American tribal organizations), public and state institutions of higher education, private institutions of higher education, independent school districts, federally recognized Native American tribal governments, public and Indian housing authorities, county governments, state governments, for-profit organizations other than small businesses, and small businesses. Confirm the full requirements in the official notice before applying.
The published deadline was February 16, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Dementia Care and Caregiver Support Intervention Research - Stage I Only is funded by National Institute on Aging (NIA), National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
NIA Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). The NIA SBIR/STTR programs support small businesses in developing technologies for aging-related health issues, including AI-driven drug discovery tools and assistive technologies for older adults aging in place. These programs aim to help small businesses develop effective treatments and interventions for healthy aging.
Small Business Technology Transfer (STTR) Program is sponsored by National Institute on Aging (NIA), National Institutes of Health (NIH). The NIA STTR program encourages small businesses to collaborate formally with research institutions to develop and commercialize innovative treatments or technologies to help people enjoy healthier lives as they age, including solutions for Alzheimer's disease and related dementias. This program supports feasibility studies to later stage research and development (R&D) needed to develop a commercial product.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article